Abnormal 18F-FDG and 18F-MFBG Uptake in the Skeletal System of an Adult Patient With Neuroblastoma in the Absence of a Detectable Primary Tumor.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 41941230.
- Also identified by DOI 10.1097/RLU.0000000000006314.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A 30-year-old woman was evaluated for recurrent fever and pancytopenia. 18F-FDG PET/CT revealed diffuse skeletal involvement, consistent with disseminated metastatic disease. Histopathologic analysis of a bone marrow biopsy confirmed the diagnosis of neuroblastoma. The patient subsequently received neuroblastoma-targeted chemotherapy. Following treatment, she participated in a clinical trial and underwent an 18F-MFBG PET/CT examination, which demonstrated multiple skeletal metastases. Notably, neither imaging modality identified a primary tumor site. This case illustrates that metastatic neuroblastoma in adults may present with extensive osseous involvement in the absence of a detectable primary tumor, even after comprehensive functional imaging with both 18F-FDG and 18F-MFBG.
Medical subject headings
- Fluorodeoxyglucose F18
- Neuroblastoma
- Bone Neoplasms
- Bone and Bones